中国乳业 ›› 2023, Vol. 0 ›› Issue (7): 103-107.doi: 10.12377/1671-4393.23.07.20

• 乳品加工 • 上一篇    下一篇

肿瘤特殊医学用途配方粉营养特点及研究进展

初百吉   

  1. 青岛圣桐营养食品有限公司北京技术中心,北京 101100
  • 出版日期:2023-07-25 发布日期:2023-08-07
  • 作者简介:初百吉(1992-),男,吉林松原人,硕士,研究方向为特殊人群营养及特膳食品。

Nutritional Characteristics and Research Progress of Formula Powder for Special Medical Use in Cancer

CHU Baiji   

  1. Qingdao Shengtong Nutritional Food Co.,Ltd.,Beijing Technology Center,Beijing 101100
  • Online:2023-07-25 Published:2023-08-07

摘要: 中国肿瘤患者数量逐年攀升,肿瘤已成为我国人口死亡主要因素之一,肿瘤患者营养不良又是导致死亡的主要原因之一,营养风险和营养不良严重影响肿瘤患者预后,降低对手术、放疗和化疗耐受性和敏感性。因此,改善肿瘤患者营养不良具有重要现实意义。肿瘤特殊医学用途配方粉(简称“肿瘤特医粉”)是根据肿瘤患者的代谢特点研制,有针对性补充营养,改善营养不良。本文对肿瘤特医粉的营养素特点及目前适用于肿瘤患者营养补充产品的研究进展进行分析,得出现适用于肿瘤患者的产品类别以药品和肠内营养制剂为主,特医类产品只有一款。

关键词: 肿瘤, 营养不良, 肿瘤特医粉, 营养补充

Abstract: The number of cancer patients in China is increasing year by year. Tumors have become one of the main factors of death in Chinese population and malnutrition of cancer patients is also one of the main causes of death. The occurrence of nutritional risk and malnutrition seriously affects the prognosis of cancer patients and reduces the tolerance and sensitivity of patients to surgery radiotherapy and chemotherapy. Therefore,how to improve the condition of malnutrition in cancer patients has very important practical significance. Tumor special medical (hereinafter referred to as "tumor special medical powder") use formula food is developed according to the metabolic characteristics of cancer patients which can provide targeted nutrition and improve the status quo of malnutrition in cancer patients. In this paper the nutrient characteristics of tumor total nutrition formula for special medical purposes and the research progress of nutritional supplement products suitable for cancer patients were analyzed.

Key words: tumor, malnutrition, tumor special medical powder, nutritional supplement

[1] 陶魏. 肿瘤患者营养不良风险与实际营养支持现状与展望[J].常州实用医学,2016,32(3):3.
[2] 刘明,石汉平,中国抗癌协会肿瘤营养与支持治疗专业委员会肿瘤营养通路学组制订,等.我国第一部 《中国恶性肿瘤营养治疗通路专家共识》(2018年)出版[J].肿瘤代谢与营养电子杂志,2018,5(3):256.
[3] 王世容. 肿瘤患者癌性疼痛和心理痛苦及营养不良的相关性研究进展[J].科学养生,2019,22(12):297.
[4] 李子建,姚玉昕,李海龙,等.住院患者肿瘤相关营养不良现况分析:一项横断面调查研究[J].中国临床医生,2016(6):19-23.
[5] 杨振丽,刘玉琴.癌症相关代谢紊乱综合征[J].中国肿瘤临床,2007,34(24):1428-1432.
[6] Lu H,Li X,Luo Z,et al.Cetuximab reverses the Warburg Effect by inhibiting HIF-1-Regulated LDH-A[J].Molecular Cancer Therapeutics,2013,12(10):2187-2199.
[7] 张帅. 肿瘤免疫营养研究概述[J].饮食科学,2019(12):268.
[8] 吴国豪. 恶性肿瘤病人恶病质发生机制及营养治疗[J].外科理论与实践. 2012,17(2):98-101.
[9] Polet F,Feron O.Endothelial cell metabolism and tumour angiogenesis:Glucose and glutamine as essential fuels and lactate as the driving force[J].Journal of Internal Medicine,2013,273(2):156-165.
[10] 黄翠花,蔡威.恶性肿瘤患者能量代谢及相关机制的研究进展[J].上海交通大学学报:医学版,2010(1):4.
[11] 康维明. 肿瘤营养治疗特点[J].肿瘤代谢与营养电子杂志,2015(1):33.
[12] 王林,丛明华,崔久嵬,等.肿瘤营养治疗的基本原则[J].肿瘤代谢与营养电子杂志,2022,9(6):727-734.
[13] 程翔燕. 基于肿瘤全营养配方的一种破壁中药特医食品的开发研究[D].广州:广州中医药大学 2017.
[14] 中国抗癌协会肿瘤营养专业委员会,中华医学会肠外肠内营养学分会组织编写.中国肿瘤营养治疗指南[M].人民卫生出版社 2020.
[15] 顾景范,杜寿玢.现代临床营养学(第2 版)[M].北京:科学出版社.2009.
[16] 李增宁,陈伟,齐玉梅,等.肿瘤患者特殊医学用途配方食品应用专家共识[J].肿瘤代谢与营养电子杂志,2016,3(2):95-99.
[17] Lien E C,Westermark A M,Zhang Y,et al.Low glycaemic diets alter lipid metabolism to influence tumour growth[J].Nature,2021,599(7884):302-307.
[18] Telessy I G.Promising perspectives of low carbohydrate diet in cancer adjuvant therapy[J].肿瘤营养学杂志(英文),2020,5(2):50-58.
[19] Penna F,Camperi A,Muscaritoli M,et al.The role of vitamin D in cancer cachexia[J].Current Opinion in Supportive & Palliative Care,2017.
[20] 田宏,李娓,李慧婷,等.肿瘤病人特殊医学用途配方食品的研究进展[J].价值工程,2017,36(14):231-233.
[21] 中国抗癌协会肿瘤营养与支持治疗专业委员会.中国肿瘤营养治疗指南[M].北京:人民卫生出版社,2015.
[1] 杜玲玲. 母乳营养补充剂营养素的稳定性研究分析[J]. 中国乳业, 2022, 0(5): 69-74.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!